Bovine respiratory disease (BRD) remains one of the most significant health and economic challenges in both beef and dairy production.

Today’s decisions, beginning even before a calf is born, can determine whether that heifer becomes a long-lasting, productive cow or falls short of her genetic potential.

By the time today’s cattle leave the feedyard, they are heavier and have been there longer than ever before. This shift has created new opportunities for efficiency and carcass value. Today, the success of feeding cattle can be largely determined long before the animal ever sees a bunk.

As producers and veterinarians consider vaccination programs, it’s important to understand the key differences between autogenous and commercial vaccines.

Late calving in a heifer’s first season is more than a timing issue – the consequences often extend beyond year one.

All producers aim to maintain the health of their herds. Because losses from sickness and death take a toll on cattle and producers alike, it can be helpful to periodically review farm biosecurity practices.

Bovine respiratory disease (BRD) is essentially pneumonia. Caused by specific bacteria and viruses, it is the most expensive disease in the beef industry.

While disease prevention remains the primary purpose of vaccine programs, a well-designed vaccination protocol is now an essential marketing strategy for producers selling calves into value-added and graded feeder sales.